To improve our understanding of locus-specific HML-2 expression in GBM cells, we conducted an unbiased transcriptomic assessment of single-cell RNA-Seq (scRNA-Seq) data from patient-derived tumor specimens. This evidence concerns the gene CLEC10A and neoplasm.